Form D Explorer

Form C-AR — iMetabolic Biopharma Corporation

0001665160-24-001088 · filed 2024-07-19

Offering

Target: —
Maximum: —
Security type: —
Price per security: —
Deadline: —
Oversubscription: —

Issuer

Name: iMetabolic Biopharma Corporation
CIK: 1957114
Entity: Corporation
Jurisdiction: NV
Address: 2155 E Conference Dr
Tempe, AZ 85284-2604
Phone: —

Most recent fiscal year financials

Total assets

$100,587

Cash

—

Short-term debt

$8,949

Long-term debt

$455,843

Revenues

$76,803

COGS

—

Taxes paid

—

Net income

$-200,806

View original on SEC EDGAR.